As a major player in the fields of research, development and innovation, the French Atomic Energy Commission (CEA) is involved in four major areas: defense and global security, energies that do not emit greenhouse gases and information and health technologies, for which it relies on high-level fundamental research.
With ten research centers set up across France, the CEA is closely involved in each region and has forged sound partnerships with businesses, other research organizations, universities and local authorities. It implements a proactive policy in terms of research promotion in the world of industry and, in this regard, in 2009 the CEA was the French National Institute for Intellectual Property’s top-ranking research organization with 416 patents registered, and in 5th place in the general rankings. In order to foster knowledge transfer and the promotion of scientific professions, it sets particular store by public information and education.
The CEA is a scientific, technical and industrial research institution with a status in France as a public industrial and commercial institution. Its 15,700 employees avail of a private law status and its budget amounts to 3.9 billion euros.
Within the CEA, the Life Sciences Department (DSV) teams conduct cutting-edge research for energy and health in such varied fields as radiobiology, nuclear and environmental toxicology, medical imaging, large-scale biology, protein engineering, bioenergies, biotechnologies ...
The DSV employs some 1,800 permanent members of personnel, 1,270 of whom are on the CEA’s wage bill. It is organized around 8 institutes and a specific research center based in Fontenay-aux-Roses. It is also responsible for the CEA’s cross-disciplinary programs dealing with health technologies and toxicology.
The DSV comprises thirty or so mixed research units (along with the French National Center for Scientific Research (CNRS), French National Institute of Health and Medical Research (Inserm), French National Institute for Agricultural Research (Inra) and universities to mention just a few partners). It has a portfolio of around 150 active patents and 35 license agreements. Since 1984, 10 start-ups from its own laboratories have been created. In 2009, its teams published 860 articles in influential scientific reviews, listed in the Web of Science.
Convinced that French research can only be stepped up through improved coordination and dialogue between its stakeholders, the CEA is a founding member of Aviesan, and of three other alliances that cover other research fields (energy: Ancre, digital sciences: Allistene and the environment: AllEnvi).
The CEA is represented within Aviesan by Gilles Bloch, Director of Life Sciences.
Moreover, the thematic multi-organization institute Health Technologies is headed up by Jacques Grassi, who also directs the cross-disciplinary program for this theme at the CEA, which represents a recognition of the CEA’s work and its teams in this field.